Mohammad Khan

Temporary treatment cessation versus continuation of first-line tyrosine kinase inhibitor in patients with advanced clear cell renal cell carcinoma (STAR): an open-label, non-inferiority, randomised, controlled, phase 2/3 trial.

V. Goh, T. Powles, M. Highley, 2023, The Lancet. Oncology.

Primary vulvar extragastrointestinal stromal tumor in a 77‐year‐old woman

G. Hosler, Katie Tumminello, N. Mohamed, 2023, Journal of cutaneous pathology.

Mesenteric desmoid tumor developing on the site of an excised gastrointestinal stromal tumor

A. Maraveyas, K. Wedgwood, G. Bozas, 2010, Rare tumors.